Moderna, it could speed up global inoculation if it proves effective.
Speaking at J.P. Morgan’s health care investor conference on Monday, Johnson & Johnson CEO Alex Gorsky said that the company aimed to have “hundreds of millions of doses” of the vaccine available in the first half of this year, and “close to one billion” by the end of the year.
“We’re still on track to be able to achieve those volumes,” Gorsky said. “And again, we’re working night and day to see what else can we do to accelerate that even more in an effective and safe, compliant, high-quality manner.”
Germany could be one of the first Western countries to start immunizing people against Covid-19 under a plan being rolled out by the government and a German company that is testing a vaccine, according to people with knowledge of the strategy.
Order Reprints Text size
Moderna’s Covid-19 vaccines are currently being distributed across the U.S. Joseph Prezioso / AFP via Getty Images
Moderna’s chief medical officer said Monday that the company expects that its Covid-19 vaccine should provide protection from the virus for a year or more.
Speaking Monday afternoon at a health-care investor conference hosted by
J.P. Morgan, Moderna (ticker: MRNA) Chief Medical Officer Tal Zaks said that the company will be tracking early recipients of the vaccine to try to determine how long the initial two-dose regimen will be effective.
“From what we’ve seen so far, I think our expectation is that the vaccination should last you at least a year,” Zaks said. “We have to follow people until we see the year. We’ll try and boost some of them to see how well a boost works.”
Order Reprints Print Article
Johnson & Johnson says it can make enough doses of its Covid-19 vaccine this year to inoculate almost a billion people against the virus.
That would be a massive shot in the arm to the effort to end the pandemic as long as the vaccine works. Its efficacy should become clear in just a few days.
Speaking at an industry conference on Monday,.
Close
Johnson & Johnson’s Covid-19 Vaccine Could Alter the Course of the Pandemic. Investors Will Soon Know if It Works.
Johnson & Johnson says it can make enough doses of its Covid-19 vaccine this year to inoculate almost a billion people against the virus.